Om

Revelation Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing immunologic therapies and diagnostics that modulate the innate immune system. Its current pipeline centers on product candidates designed to address inflammatory and infectious disease settings, including treatments for allergic rhinitis and chronic nasal congestion, rapid home-use diagnostics for respiratory viral infections, and intranasal immunomodulator approaches used alongside vaccination. The company also works on therapeutic programs targeting acute kidney injury, chronic kidney disease, and other conditions linked to dysregulated inflammation. Revelation Biosciences Inc. develops products intended for use in prevention and treatment across hospital, outpatient, and at-home care settings, with a focus on clinically relevant immune-response modulation. Based in San Diego, California, the company operates in the biotechnology sector and maintains a narrow, research-driven portfolio aimed at immune system therapeutics and diagnostics.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I REVELATION BIOSCIENCES MED ENDAVU: Køb Revelation Biosciences ($REVB) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Revelation Biosciences, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.